Shenzhen Chipscreen Biosciences CoのEV/Sales

Shenzhen Chipscreen Biosciences CoのEV/Salesは何ですか。

Shenzhen Chipscreen Biosciences Co., Ltd.のEV/Salesは17.04です。

EV/Salesの定義は何ですか。



Enterprise value to sales ratio compares a company’s total value to its sales.

ttm (trailing twelve months)

Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.

EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.

SSEのセクタHealth CareにおけるEV/Salesの企業と比べるShenzhen Chipscreen Biosciences Co

Shenzhen Chipscreen Biosciences Coは何をしますか。

Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of original small molecule drugs. The company develops precursor compounds and original new drug product lines that are in various research phase of the specific global intellectual property protection in three areas, such as cancer, metabolic diseases, and autoimmune diseases. Shenzhen Chipscreen Biosciences Co., Ltd. was founded in 2001 and is based in Shenzhen, China.

Shenzhen Chipscreen Biosciences Coと類似のev/sales